Compare SHASUN PHARMA with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA ALEMBIC PHARMA SHASUN PHARMA/
ALEMBIC PHARMA
 
P/E (TTM) x 123.9 15.6 794.5% View Chart
P/BV x 8.5 3.6 237.7% View Chart
Dividend Yield % 0.2 1.1 22.0%  

Financials

 SHASUN PHARMA   ALEMBIC PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
ALEMBIC PHARMA
Mar-19
SHASUN PHARMA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs94664 14.2%   
Low Rs46412 11.1%   
Sales per share (Unadj.) Rs214.2208.7 102.6%  
Earnings per share (Unadj.) Rs5.331.0 17.2%  
Cash flow per share (Unadj.) Rs15.837.1 42.6%  
Dividends per share (Unadj.) Rs1.005.50 18.2%  
Dividend yield (eoy) %1.41.0 140.0%  
Book value per share (Unadj.) Rs53.3144.2 37.0%  
Shares outstanding (eoy) m56.62188.52 30.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.32.6 12.7%   
Avg P/E ratio x13.117.4 75.4%  
P/CF ratio (eoy) x4.414.5 30.5%  
Price / Book Value ratio x1.33.7 35.1%  
Dividend payout %18.717.7 105.6%   
Avg Mkt Cap Rs m3,958101,461 3.9%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1647,467 29.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12,12739,347 30.8%  
Other income Rs m22994 244.5%   
Total revenues Rs m12,35639,441 31.3%   
Gross profit Rs m1,0098,736 11.6%  
Depreciation Rs m5941,152 51.5%   
Interest Rs m415184 225.5%   
Profit before tax Rs m2307,493 3.1%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-93 0.3%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-731,568 -4.6%   
Profit after tax Rs m3025,844 5.2%  
Gross profit margin %8.322.2 37.5%  
Effective tax rate %-31.720.9 -151.3%   
Net profit margin %2.514.9 16.8%  
BALANCE SHEET DATA
Current assets Rs m6,88419,577 35.2%   
Current liabilities Rs m8,45614,896 56.8%   
Net working cap to sales %-13.011.9 -108.9%  
Current ratio x0.81.3 61.9%  
Inventory Days Days6290 68.7%  
Debtors Days Days10845 237.1%  
Net fixed assets Rs m4,97027,097 18.3%   
Share capital Rs m113377 30.1%   
"Free" reserves Rs m2,87526,811 10.7%   
Net worth Rs m3,02027,188 11.1%   
Long term debt Rs m1,8174,993 36.4%   
Total assets Rs m13,34747,778 27.9%  
Interest coverage x1.641.7 3.7%   
Debt to equity ratio x0.60.2 327.7%  
Sales to assets ratio x0.90.8 110.3%   
Return on assets %5.412.6 42.6%  
Return on equity %10.021.5 46.5%  
Return on capital %13.323.6 56.4%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,84319,453 30.0%   
Fx outflow Rs m2,1736,065 35.8%   
Net fx Rs m3,66913,388 27.4%   
CASH FLOW
From Operations Rs m3988,120 4.9%  
From Investments Rs m-1,635-7,556 21.6%  
From Financial Activity Rs m1,309590 221.6%  
Net Cashflow Rs m711,153 6.2%  

Share Holding

Indian Promoters % 39.2 74.1 52.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 2.9 124.1%  
FIIs % 17.6 9.1 193.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 13.9 284.9%  
Shareholders   20,750 49,328 42.1%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   JUBILANT LIFE SCIENCES  PANACEA BIOTECH  WOCKHARDT  GSK PHARMA  PLETHICO PHARMA  

Compare SHASUN PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9% (Quarterly Result Update)

May 9, 2019 | Updated on May 9, 2019

For the quarter ended March 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.6% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 61.0% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 11 bn (up 42.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS